Chiasma Inc.

Chiasma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
24.39 M
Public Float
12.61 M
Chiasma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.35
Market Cap
$187.51 M
Shares Outstanding
31.73 M
Public Float
13.56 M

Profile

Address
460 Totten Pond Road
Waltham Massachusetts 02451
United States
Employees -
Website http://www.chiasmapharma.com
Updated 07/08/2019
Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The company's Transient Permeability Enhancer (TPE) technology platform, seeks to develop oral medications.

Financials

View All
Created with Highcharts 5.0.14Chiasma Inc.Net Income. Fiscal year is January-December. All values USD Thousands.36 18136 1812 0102 01035 90835 90861 11161 11126 82626 82631 26131 261201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Chiasma Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.73 13473 13413 16513 1650000008888201320142015201620172018020k40k60k80k

Mark J. Fitzpatrick
President, Chief Executive Officer & Director
Roni Mamluk
Director